Shenzhen Kangtai Biological Products Co., Ltd. engages in the manufacture, sale, and research and development of human vaccines. Its products include cell free haemophilus infuenzae type b vaccine, measles rubella vaccine, haemophilus influenzae type b conjugate vaccine, recombinant hepatitis B vaccine, and liver vaccine. The company was founded on September 8, 1992 and is headquartered in Shenzhen, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company